CAS: 628-34-2; 2-Chloroethylethylether

该化合物是一种该化合物是一种明显,挥发性液体,其应用在有机合成中具有中间作用,特别是在生产药品,农用化学品和特殊化学品方面.该化合物的活性氯乙基组体使它成为发烧和发热反应的宝贵建筑块.其中度沸点和普通有机溶剂溶解性有利于实验室和工业环境中的处理.建议适当储存在惰性条件下,因为它对水分和潜在反应具有敏感性.应当遵守安全防范措施,包括使用个人防护设备,因为其刺激性.

结构式图片

相似化合物

42149-74-6 627-42-9 41771-35-1

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

2-ethoxy-ethanol diethyl acetal N,N-Dichlorobenzenesulfonamide ethanol bis-(2-ethoxyethyl)amine monoethylene glycol diethyl ether 1-ethyl-4-phenylethylene glycol 2-iodoethyl ethyl ether

合成工艺路线路线简述

  • 合成目标产物 2-Chloroethyl Ethyl Ether 主要起始原料 Ethanol And Acetaldehyde
  • (文献来源)合成步骤主要原料 Ethanol 和 Acetaldehyde
乙二醇乙醚置于吡啶,氯化亚砜体系中,用 苯 作为反应溶剂,化学反应 16.0H,反应生成 2-乙氧基氯乙烷
参考文献:冠状螺并噻吩并吡喃的合成和光致变色作用:通过冠醚和硫酚盐部分与金属离子的协同络合促进光致异构化.
标题:冠状螺并噻吩并吡喃的合成和光致变色作用:通过冠醚和硫酚盐部分与金属离子的协同络合促进光致异构化.
摘要:合成了带有单氮杂-12-冠-4,-15-冠-5,-18-冠-6和低聚氧乙烯部分的螺并苯并噻喃,并在乙腈中存在阳离子的情况下检查了它们的光致变色.与相应的螺并苯并吡喃衍生物不同,通过它们的冠醚部分进行的阳离子络合不能诱导热异构化为其相应的有色花菁形式.然而,冠醚部分的阳离子络合以及花青硫酚盐阴离子对金属离子的亲和力,尤其是在li(+)和ag(+)的存在下,促进了紫外线诱导的异构化.
DOI:10.1021/jo000175R

海关参考信息

专利信息


专利号:US-11548898-B2
优先权日:2017-07-06
标题 :Synthesis of halichondrins
发明人:KISHI YOSHITO; AI YANRAN; YE NING; WANG QIAOYI; YAHATA KENZO; ISO Kentaro; NAINI SANTHOSH REDDY; YAMASHITA SHUJI; LEE JIHOON; OHASHI ISAO; FUKUYAMA TAKASHI
权利人:HARVARD COLLEGE; EISAI R&D MAN CO LTD
摘要:The present invention provides methods for the synthesis of ketones involving a Ni/Zr-mediated coupling reaction. The Ni/Zr-mediated ketolization reactions can be used in the synthesis of halichondrins (e.g., halichondrin A, B, C; homohalichondrin A, B, C; norhalichondrin A, B, C), and analogs thereof. Therefore, the present invention also provides synthetic methods useful for the synthesis of halichondrins, and analogs thereof. Also provided herein are compounds (i.e., intermediates) useful in the synthesis of halichondrins, and analogs thereof. In particular, the present invention provides methods and compounds useful in the synthesis of compound of Formula (H3-A).

专利号:US-2004242897-A1
优先权日:2002-07-31
标题 :Universal support media for synthesis of oligomeric compounds
发明人:GUZAEV ANDREI P; MANOHARAN MUTHIAH
摘要:Compounds for the synthesis of oligomeric compounds, particularly oligonucleotides and oligonucleotide mimetics, are provided. In addition, methods for functionalizing a support medium with a first monomeric subunit and methods for the synthesis of oligomeric compounds utilizing the novel compounds bound to support media are provided.

专利号:US-10751419-B2
优先权日:2014-05-01
标题:Method for synthesis of reactive conjugate clusters
发明人:MIGAWA MICHAEL T; YU JINGHUA; WAN W BRAD; PATEL SAYTEN P; VASQUEZ GUILLERMO; KINBERGER GARTH A; PRAKASH THAZHA P; SETH PUNIT P; SWAYZE ERIC E
权利人:IONIS PHARMACEUTICALS INC
摘要:Provided herein are improved methods for the synthesis of reactive conjugate clusters and intermediates used in such methods. In particular, improvements are provided that enhance the synthesis of reactive conjugate clusters by reducing the number of synthetic steps required. The reactive conjugate clusters prepared using the improved methods don't include any transacylation impurities that are formed using existing methods. The improved methods also provide an increase in overall yield and a cost benefit over existing methods.

专利号:US-2006287520-A1
优先权日:2005-05-16
标 题 :Synthesis of salinosporamide A and analogues thereof
发明人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
权利人:DANISHEFSKY SAMUEL J; ENDO ATSUSHI
摘要:A novel synthesis of salinosporamide A is provided. Salinospoamide A as well as structurally related natural products, omuralide and lactacystin, have been shown to be proteasome inhibitors. Therefore, these compounds as well as analogues of these natural products may be useful in the treatment of proliferative diseases such as cancer, autoimmune diseases, diabetic retinopathy, etc. The invention provides for the synthesis of salinosporamide A as well as analogs thereof using a convenient point for derivatization of the bicyclic core. Pharmaceutical compositions and method of using the inventive compounds are also provided.

专利号:US-5623068-A
优先权日:1994-03-07
标 题:Synthesis of DNA using substituted phenylacetyl-protected nucleotides
发明人:REDDY M PARAMESWARA; FAROOQUI FIRDOUS; HANNA NAEEM B
权利人:BECKMAN INSTRUMENTS INC
摘要:Deoxyribonucleotide and ribonucleotide derivatives of the general formula I I wherein R1 represents -CR'R''-Ar, in which Ar is substituted aryl (as hereinafter defined) and R' and R'' are independently selected from the group consisting of hydrogen and lower alkyl; one of -R2 and R3 is a hydroxyl-protecting group and the other is a group suitable for synthesis of polynucleotides or for attachment of the nucleotide to a solid support; R4 is selected from the group consisting of hydrogen, -OH and protected hydroxyl; and B represents a divalent radical corresponding to a purine or pyrimidine base. When synthesis is carried out using these derivatives, the deprotection procedure is reduced to an essentially instantaneous process. The derivatives have acceptable shelf life and are very stable to conventional DNA synthesis conditions. Particularly preferred are those compounds wherein Ar is mono- and dihalo-substituted phenyl.

专利号:US-7910623-B2
优先权日:2005-07-22
标 题 :Synthesis of scabronines and analogues thereof
发明人:DANISHEFSKY SAMUEL J; WATERS STEPHEN P
权利人:SLOAN KETTERING INST CANCER
摘要:A novel synthesis of scabronines, which are related to a broader class of angularly fused tricyclic diterpenoids known as cyathanes, is provided. Scabronine G, its methyl ester derivative, and other analogs have been shown to have neurotrophic activity. Therefore, these compounds are particularly useful in treating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's diseases, etc. The invention provides for the synthesis of scabronines as well as analogs thereof. Pharmaceutical compositions and method of using the inventive compounds are also provided.
扬州市普林斯医药科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.princechem.cn
企业联系电话:吴宇皓18752736070,郭跃18936227980👤
📞扬州市普林斯医药科技有限公司 ⚠️参考联系方式
联系人:吴宇皓;郭跃
电话:吴宇皓18752736070,郭跃18936227980
手机:吴宇皓18752736070

邮箱:david@princechem.com;remi@princechem.com;chen@princechem.com
通信地址: 扬州市高新技术开发区吉安南路158号金荣科技园B8栋6楼
邮编: 225000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:扬州市高新技术开发区吉安南路158号金荣科技园B8栋6楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
聊城金信达新材料有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jinxindachem.com
企业联系电话:18906354373,18053859701👤
📞聊城金信达新材料有限公司 ⚠️参考联系方式
联系人:孙总
电话:18906354373,18053859701

传真:QQ 3819325921
邮箱:sunjingbiao1@sina.com
通信地址: 山东省聊城市高新区九州街道长江路北燕山路西华建1街区小区8号商办楼8层8-0810室
邮编: 252000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:山东省聊城市高新区九州街道长江路北燕山路西华建1街区小区8号商办楼8层8-0810室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
铜陵立事达化学科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.lishidachem.cn
企业联系电话:18606623089;19064063435👤
📞铜陵立事达化学科技有限公司 ⚠️参考联系方式
联系人:瞿先生;刘经理
电话:18606623089;19064063435
手机:18606623089;19064063435

邮箱:350737036@qq.com
通信地址: 安徽省铜陵市郊区陈瑶湖镇其凤村向东路192号
邮编: 244061
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:安徽省铜陵市郊区陈瑶湖镇其凤村向东路192号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Kleemann A., Kutscher B., Reichert D., Bossart M., Pharmaceutical Substances, Thieme [Online], Stuttgart, (2025).
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知